Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Current Pharmaceutical Design
|
February 14, 2006
Neuroprotective therapies for Alzheimer's disease
Anke Huber, Grant Stuchbury, Alexander Bürkle, et al.
Current Opinion in Pharmacology
|
August 25, 2015
Engineering the AAV capsid to optimize vector-host-interactions
Hildegard Büning, Anke Huber, Liang Zhang, et al.
Virology
|
November 21, 2009
Optimization of stealth adeno-associated virus vectors by randomization of immunogenic epitopes
Stephan Maersch, Anke Huber, Hildegard Büning, et al.
Combinatorial Chemistry & High Throughput Screening
|
March 14, 2008
Artificial evolution with adeno-associated viral libraries
Luca Perabo, Anke Huber, Stephan Märsch, et al.
Journal of Dentistry
|
April 14, 2009
Efficient gene transfer to periodontal ligament cells and human gingival fibroblasts by adeno-associated virus vectors
Melanie Kunze, Anke Huber, Anna Krajewski, et al.
The Journal of Gene Medicine
|
September 25, 2009
Engineering adeno-associated virus serotype 2-based targeting vectors using a new insertion site-position 453-and single point mutations
Jorge Boucas, Kerstin Lux, Anke Huber, et al.
Experimental Hematology
|
May 8, 2010
Gene transfer into human cord blood-derived CD34(+) cells by adeno-associated viral vectors
Natascha K Schuhmann, Ombretta Pozzoli, Jessica Sallach, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 29, 2014
Tropism-modified AAV vectors overcome barriers to successful cutaneous therapy
Jessica Sallach, Giovanni Di Pasquale, Fernando Larcher, et al.
Hepatology (Baltimore, Md.)
|
March 21, 2017
Autophagy determines efficiency of liver-directed gene therapy with adeno-associated viral vectors
Marianna Hösel, Anke Huber, Susanne Bohlen, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Current Pharmaceutical Design
|
February 14, 2006
Neuroprotective therapies for Alzheimer's disease
Anke Huber, Grant Stuchbury, Alexander Bürkle, et al.
Current Opinion in Pharmacology
|
August 25, 2015
Engineering the AAV capsid to optimize vector-host-interactions
Hildegard Büning, Anke Huber, Liang Zhang, et al.
Virology
|
November 21, 2009
Optimization of stealth adeno-associated virus vectors by randomization of immunogenic epitopes
Stephan Maersch, Anke Huber, Hildegard Büning, et al.
Combinatorial Chemistry & High Throughput Screening
|
March 14, 2008
Artificial evolution with adeno-associated viral libraries
Luca Perabo, Anke Huber, Stephan Märsch, et al.
Journal of Dentistry
|
April 14, 2009
Efficient gene transfer to periodontal ligament cells and human gingival fibroblasts by adeno-associated virus vectors
Melanie Kunze, Anke Huber, Anna Krajewski, et al.
The Journal of Gene Medicine
|
September 25, 2009
Engineering adeno-associated virus serotype 2-based targeting vectors using a new insertion site-position 453-and single point mutations
Jorge Boucas, Kerstin Lux, Anke Huber, et al.
Experimental Hematology
|
May 8, 2010
Gene transfer into human cord blood-derived CD34(+) cells by adeno-associated viral vectors
Natascha K Schuhmann, Ombretta Pozzoli, Jessica Sallach, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 29, 2014
Tropism-modified AAV vectors overcome barriers to successful cutaneous therapy
Jessica Sallach, Giovanni Di Pasquale, Fernando Larcher, et al.
Hepatology (Baltimore, Md.)
|
March 21, 2017
Autophagy determines efficiency of liver-directed gene therapy with adeno-associated viral vectors
Marianna Hösel, Anke Huber, Susanne Bohlen, et al.
Page
of 1